The global implantable collamer lens market is set to experience remarkable expansion in the coming decade, driven by the increasing adoption of minimally invasive vision correction procedures. Market ...

Un turista de Florida que visitaba el Parque Nacional de Yellowstone fue corneado por un bisonte, en el primer encuentro ...

Northwestern Medicine investigators have developed first-of-its-kind eyedrops that use synthetic nanoparticles to help the ...

Director of Princess Basma Teaching Hospital Ibrahim Shahabat Wednesday inaugurated a specialized clinic for keratoconus treatment in the hospital's outpatient ward. He commended "the great efforts" ...

Nearsightedness is clearly seeing objects up close, while objects in the distance are blurry. The opposite is true of ...

From websites to support ECPs to contacts lenses that reshape the cornea while kids sleep, the technology is progressing almost as fast as the rates of myopia themselves.

The Food and Drug Administration has granted Fast Track designation to urcosimod for the treatment of neuropathic corneal pain.

Using lasers, doctors can alter cornea pigments. The FDA doesn't regulate this growing practice — is it worth it?

The University of South Florida uses 3D printing to enhance dry eye disease research by mimicking the curvature of the cornea ...

At Phoenixville Hospital, a live organ donor was a guest at the hospital’s flag-raising ceremony. The organ donor shared her ...

The FDA granted fast track designation to urcosimod to treat neuropathic corneal pain, according to a press release from Okyo Pharma. Urcosimod, formerly called OK-101, is a “lipid conjugated chemerin ...

Urcosimod has received FDA fast track designation for neuropathic corneal pain, enabling expedited regulatory processes and ...